Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 189, 1219-1220 [2016-233]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 6 / Monday, January 11, 2016 / Notices
Dated: January 6, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–271 Filed 1–8–16; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0008]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection Application for
Procurement Quota for a Controlled
Substance and for Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine DEA Form 250
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until March
11, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Barbara J. Boockholdt, Office of
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:17 Jan 08, 2016
Jkt 238001
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Procurement Quota for
Controlled Substance and for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine (DEA Form 250).
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form Number: DEA Form 250. The
applicable component within the
Department of Justice is the Drug
Enforcement Administration, Office of
Diversion Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Any United States
companies that desire to use any basic
class of controlled substances listed in
schedule I or II or the List I chemicals
ephedrine, pseudoephedrine, or
phenylpropanolamine for purposes of
manufacturing during the next calendar
year shall apply on DEA Form 250 for
a procurement quota for such class.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that each
form takes 0.5 hours to complete. In
total, 417 respondents submit 2,960
responses, with each response taking 0.5
hours to complete.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 1,480 annual
burden hours.
If additional information is required
please contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite 3E.405B,
Washington, DC 20530.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
1219
Dated: January 5, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–234 Filed 1–8–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0006]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Individual Manufacturing Quota for a
Basic Class of Controlled Substance
and for Ephedrine, Pseudoephedrine,
and Phenylpropanolamine DEA Form
189
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until March
11, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Barbara J. Boockholdt, Office of
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
— Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
— Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
SUMMARY:
E:\FR\FM\11JAN1.SGM
11JAN1
1220
Federal Register / Vol. 81, No. 6 / Monday, January 11, 2016 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
— Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
— Minimize the burden of the
collection of information on those
who are to respond, including
through the use of appropriate
automated, electronic, mechanical, or
other forms of information
technology, e.g., permitting electronic
submission of responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Individual
Manufacturing Quota for a Basic Class
of Controlled Substance and for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine (DEA Form 189).
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form Number: DEA Form 189. The
applicable component within the
Department of Justice is the Drug
Enforcement Administration, Office of
Diversion Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: The Controlled Substance
Act (CSA) require that any person who
is registered to manufacture any basic
class of controlled substances listed in
Schedule I or II and who desires to
manufacture a quantity of such class; or
who desires to manufacture using the
List I chemicals ephedrine,
pseudoephedrine, or
phenylpropanolamine, must complete
the DEA Form 189 online, for a
manufacturing quota for such quantity
of such class or List I chemical.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that each
form takes 0.5 hours to complete. In
total, 34 respondents submit 660
responses, with each response taking 0.5
hours to complete.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 330 annual
burden hours.
If additional information is required
please contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
VerDate Sep<11>2014
18:17 Jan 08, 2016
Jkt 238001
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite 3E.405B,
Washington, DC 20530.
Dated: January 5, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–233 Filed 1–8–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1140–0081]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Appeals of
Background Checks
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF), will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies.
DATES: Comments are encouraged and
will be accepted for 60 days until March
11, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Shawn Stevens, Federal Explosives
Licensing Center, 244 Needy Road,
Martinsburg, WV 25405, at email or
telephone number: Shawn.C.Stevens@
usdoj.gov or 1–877–283–3352.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 9990
including the validity of the
methodology and assumptions used;
• Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Extension of a currently approved
collection.
2. The Title of the Form/Collection:
Appeals of Background Checks.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): None.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals or households.
Other (if applicable): Businesses or
other non-profit.
Abstract: This collection allows
responsible person or employee to
challenge an adverse background check
determination by submitting
appropriate documentation to the ATF.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 500 respondents
will take 2 hours to complete the
survey.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
1,000 hours.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Room 3E–
405B, Washington, DC 20530.
Dated: January 5, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–225 Filed 1–8–16; 8:45 am]
BILLING CODE 4410–FY–P
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 81, Number 6 (Monday, January 11, 2016)]
[Notices]
[Pages 1219-1220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-233]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0006]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Application for Individual Manufacturing Quota for a Basic
Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and
Phenylpropanolamine DEA Form 189
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
March 11, 2016.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Barbara J. Boockholdt, Office of
Diversion Control, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
598-6812.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
-- Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
-- Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
[[Page 1220]]
-- Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
-- Minimize the burden of the collection of information on those who
are to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Individual
Manufacturing Quota for a Basic Class of Controlled Substance and for
Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189).
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: Form Number: DEA Form 189.
The applicable component within the Department of Justice is the Drug
Enforcement Administration, Office of Diversion Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): None.
Abstract: The Controlled Substance Act (CSA) require that any
person who is registered to manufacture any basic class of controlled
substances listed in Schedule I or II and who desires to manufacture a
quantity of such class; or who desires to manufacture using the List I
chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must
complete the DEA Form 189 online, for a manufacturing quota for such
quantity of such class or List I chemical.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that each form takes 0.5 hours to complete. In total, 34 respondents
submit 660 responses, with each response taking 0.5 hours to complete.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates that this collection
takes 330 annual burden hours.
If additional information is required please contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC
20530.
Dated: January 5, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-233 Filed 1-8-16; 8:45 am]
BILLING CODE 4410-09-P
